|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016360,
umls-concept:C0021735,
umls-concept:C0023413,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0205179,
umls-concept:C0282461,
umls-concept:C0679729,
umls-concept:C0936012,
umls-concept:C1518578,
umls-concept:C1527249
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1996-11-12
|
|
pubmed:abstractText |
To investigate if double modulation of fluorouracil (5-FU) with leucovorin (folinic acid [FA]) and interferon alfa-2b (IFN 2b) improves responses and survival in comparison to single modulation of 5-FU with FA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2682-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8874327-Adult,
pubmed-meshheading:8874327-Aged,
pubmed-meshheading:8874327-Antidotes,
pubmed-meshheading:8874327-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8874327-Colonic Neoplasms,
pubmed-meshheading:8874327-Disease-Free Survival,
pubmed-meshheading:8874327-Female,
pubmed-meshheading:8874327-Fluorouracil,
pubmed-meshheading:8874327-Humans,
pubmed-meshheading:8874327-Interferon-alpha,
pubmed-meshheading:8874327-Leucovorin,
pubmed-meshheading:8874327-Male,
pubmed-meshheading:8874327-Middle Aged,
pubmed-meshheading:8874327-Prospective Studies,
pubmed-meshheading:8874327-Recombinant Proteins,
pubmed-meshheading:8874327-Rectal Neoplasms
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
|
|
pubmed:affiliation |
Department of Oncology, Metaxa Cancer Hospital, Piraeus, Greece. thayos@matrix.kapatel.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
